Phair Pricing Act of 2019
Latest action · Mar 4, 2019 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 4, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Phair Pricing Act of 2019
This bill requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale.
Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager.
Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.
Cosponsors 14
Members who signed on, in the order they did. Signatures ran from May 21, 2019 to Sep 24, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-WV | Shelley Moore Capito | May 21, 2019 | |
| R-MS | Cindy Hyde-Smith | May 22, 2019 | |
| R-GA | David Perdue | May 22, 2019 | |
| D-MT | Jon Tester | May 22, 2019 | |
| R-TN | Marsha Blackburn | May 22, 2019 | |
| R-AR | Tom Cotton | May 22, 2019 | |
| R-ND | Kevin Cramer | May 23, 2019 | |
| D-WV | Joe Manchin III | Jun 4, 2019 | |
| R-AR | John Boozman | Jun 4, 2019 | |
| R-MS | Roger F. Wicker | Jun 4, 2019 | |
| R-OK | James Lankford | Jun 18, 2019 | |
| R-IA | Joni Ernst | Jul 16, 2019 | |
| R-ME | Susan M. Collins | Jul 18, 2019 | |
| D-AL | Doug Jones | Sep 24, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Mar 4, 2019 |
Actions 2
Everything that happened, newest first.
- Mar 4, 2019Introduced in Senate
- Mar 4, 2019Read twice and referred to the Committee on Finance.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 116-415 | DRUG PRICING IN AMERICA: A PRESCRIPTION FOR CHANGE, PART III275 pages | Finance Committee | Apr 9, 2019 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1034 | Phair Pricing Act of 2019 | Identical bill | Feb 7, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes.
- Short Title(s) as Introduced
- Phair Pricing Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Mar 4, 2019Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
